Breast Cancer
Breast cancer is a type of cancer that forms in the cells of the breasts, often presenting as a lump or mass. It can affect both men and women, though it is much more common in women.
Melanoma, Breast Cancer, and Head & Neck Cancer: Contrast-Enhanced Ultrasound Study
We are exploring whether contrast-enhanced ultrasound can better locate sentinel nodes during surgery compared to the current standard method. This study aims to improve detection and potentially predict if the nodes are cancerous.
1-2 yearsEfficacy phase (II)Confirmation phase (III)No PlaceboStandard MedicinesGynecology and ObstetricsOncologyOtolaryngology
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Melanoma
Melanoma is a serious form of skin cancer that develops from melanocytes, the cells that produce pigment. It often appears as a new or changing mole and can spread to other parts of the body if not treated early.
Head and Neck Cancer
Head and neck cancer refers to a group of cancers that develop in the mouth, throat, larynx, or sinuses. Symptoms can vary widely depending on the specific area affected.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you 18 years old or older?
- Have you been diagnosed with cancer in the skin (melanoma), breast, or head & neck?
- Is your melanoma located in the limbs or head and neck area?
- Are you currently pregnant?
- Do you have any known severe allergies to eggs or egg products?
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting
Surgery
Amstelveen, Netherlands
Sponsor: Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.